Allworth Financial LP Kazia Therapeutics LTD Transaction History
Allworth Financial LP
- $15.5 Billion
- Q2 2024
A detailed history of Allworth Financial LP transactions in Kazia Therapeutics LTD stock. As of the latest transaction made, Allworth Financial LP holds 87 shares of KZIA stock, worth $33. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87
Previous 87
-0.0%
Holding current value
$33
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding KZIA
# of Institutions
13Shares Held
328KCall Options Held
24KPut Options Held
0-
Morgan Stanley New York, NY201KShares$78,4210.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA41.5KShares$16,1760.0% of portfolio
-
Virtu Financial LLC New York, NY39.3KShares$15,3180.0% of portfolio
-
Ubs Group Ag23.3KShares$9,1010.0% of portfolio
-
Rhumbline Advisers Boston, MA17.6KShares$6,8690.0% of portfolio
About KAZIA THERAPEUTICS LTD
- Ticker KZIA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,111,300
- Market Cap $5.89M
- Description
- Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various...